The healthcare sector has suffered a dip in public trust in major markets including France, India and the US, but Britons remain among the more trusting globally, according to the Edelman Health Trust Barometer.
Intriguing data on the economics and impact of co-pay coupons and programs
What happens in the world of Facebook cannot be ignored in pharma marketing. It increasingly lives in a world of data that is highly sensitive and must be managed well.
Whether it’s data or marketing dollars, there should be no surprises when you partner with a company.
In 2013, Medicare Part D prescribers who received a gift from a drugmaker prescribed 8% more brand-name drugs.
New research suggests that the oft-cited $2.6 billion estimate for bringing a drug to market is significantly overstated.
Images that “mirror the demographic profile of their target audience” perform best, according to an eye-tracking study from picture provider Shutterstock.
This includes Sarepta Therapeutics’ Exondys 5 and Vertex Pharmaceuticals’ Orkambi.
Drugmakers and providers alike struggle to find the best tools, words, and technologies that will improve adherence rates among patients with chronic diseases.
Drugs approved through the accelerated approval pathway, as well as psychiatric drugs, were more likely to have a safety issue following FDA approval.
Please login or register first to view this content.
